Effect of Aromatherapy on the Management of Chemotherapy-Induced Neuropathy (CIN)

NCT07779135 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2026-08-21

No results posted yet for this study

Summary

The main objective of this study is to describe the effect of an essential oil-based blend applied topically in the management of painful symptoms, sensory disturbances, or functional impairment caused by Chemotherapy-Induced Neuropathy (CIN) in breast cancer patients who have undergone paclitaxel treatment.

Conditions

Sponsors & Collaborators

  • Centre Hospitalier de Colmar

    lead OTHER

Principal Investigators

  • Karine Demesmay · Hopitaux Civils de Colmar

  • Emilie Hutt · Hopitaux Civils de Colmar

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2027-05-15
Completion
2027-09-15

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07779135 on ClinicalTrials.gov